Free Trial

Liberty One Investment Management LLC Lowers Position in Amdocs Limited $DOX

Amdocs logo with Computer and Technology background

Key Points

  • Liberty One Investment Management LLC reduced its stake in Amdocs Limited by 5.3%, now holding approximately 206,657 shares valued at about $18.86 million.
  • Amdocs recently announced a quarterly dividend of $0.527 per share, resulting in a yield of 2.6%.
  • The company reported a quarterly earnings per share (EPS) of $1.72, slightly exceeding analyst expectations, despite a year-over-year revenue decline of 8.4%.
  • MarketBeat previews top five stocks to own in November.

Liberty One Investment Management LLC lessened its holdings in Amdocs Limited (NASDAQ:DOX - Free Report) by 5.3% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 206,657 shares of the technology company's stock after selling 11,491 shares during the period. Amdocs accounts for approximately 1.9% of Liberty One Investment Management LLC's portfolio, making the stock its 24th largest holding. Liberty One Investment Management LLC owned approximately 0.18% of Amdocs worth $18,855,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Cornerstone Planning Group LLC purchased a new stake in Amdocs during the first quarter valued at about $27,000. Quarry LP increased its holdings in Amdocs by 42.2% during the 1st quarter. Quarry LP now owns 391 shares of the technology company's stock valued at $36,000 after purchasing an additional 116 shares during the period. Cullen Frost Bankers Inc. purchased a new position in Amdocs during the 1st quarter valued at about $39,000. SVB Wealth LLC bought a new stake in Amdocs during the 1st quarter valued at approximately $43,000. Finally, Geneos Wealth Management Inc. boosted its position in Amdocs by 213.9% during the 1st quarter. Geneos Wealth Management Inc. now owns 700 shares of the technology company's stock valued at $64,000 after acquiring an additional 477 shares in the last quarter. Hedge funds and other institutional investors own 92.02% of the company's stock.

Amdocs Trading Down 0.4%

Shares of Amdocs stock opened at $82.64 on Tuesday. The firm has a market cap of $9.33 billion, a price-to-earnings ratio of 16.76, a PEG ratio of 1.38 and a beta of 0.51. The business has a 50-day moving average price of $84.34 and a 200-day moving average price of $87.39. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 0.23. Amdocs Limited has a twelve month low of $78.61 and a twelve month high of $95.41.

Amdocs (NASDAQ:DOX - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The technology company reported $1.72 EPS for the quarter, topping the consensus estimate of $1.71 by $0.01. The company had revenue of $1.14 billion during the quarter, compared to analyst estimates of $1.13 billion. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.The firm's revenue was down 8.4% on a year-over-year basis. During the same quarter last year, the business posted $1.62 earnings per share. Equities research analysts anticipate that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be given a $0.527 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $2.11 annualized dividend and a yield of 2.6%. Amdocs's dividend payout ratio (DPR) is currently 42.60%.

Analysts Set New Price Targets

A number of analysts have recently commented on DOX shares. Wolfe Research started coverage on Amdocs in a research report on Tuesday, July 8th. They issued an "outperform" rating on the stock. Wall Street Zen raised Amdocs from a "hold" rating to a "buy" rating in a research report on Saturday, October 11th. Finally, Weiss Ratings reissued a "hold (c+)" rating on shares of Amdocs in a report on Wednesday, October 8th. Three investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $108.00.

Get Our Latest Stock Report on DOX

About Amdocs

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Read More

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX - Free Report).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amdocs Right Now?

Before you consider Amdocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.

While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.